Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor

Inventiva, a clinical-stage biopharmaceutical company, announced the appointment of three new members to its leadership team: Axel-Sven Malkomes as Chief Financial Officer, Susan Coles as Chief Legal Officer, and Pamela Herbster as Chief People Officer. These strategic hires aim to bolster the company’s capabilities in finance, legal, and human resources as it prepares for the anticipated top-line data readout from the NATiV3 Phase 3 trial for lanifibranor in Q4 2026, marking a significant step towards potential commercialization. The existing CFO and Head of HR will transition into new roles to continue supporting the company’s growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin